Impact of diabetes mellitus on angiographic and clinical outcomes in the drug-eluting stents era

Tae Hyun Yang, Seong Wook Park, Myeongki Hong, Duk Woo Park, Kyoung Min Park, Young Hak Kim, Ki Hoon Han, Whan Lee Cheol, Sang Sig Cheong, Jae Joong Kim, Seung Jung Park

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

The effect of diabetes mellitus (DM) on angiographic restenosis and clinical outcomes after implantation of drug-eluting stents (DESs) has not been investigated in real-world practice. This study consisted of 226 patients who had DM and 560 patients who did not who underwent DES implantation between February 2003 and December 2003. We retrospectively compared the incidence of 6-month angiographic restenosis and 9-month major adverse cardiac events (MACEs), defined as cardiac death, myocardial infarction, and target lesion revascularization, between patients with and without DM. The 6-month angiographic restenotic rate (10.1% vs 8.2%, p = 0.41) and late loss (0.41 ± 0.63 vs 0.36 ± 0.65, p = 0.31) were similar between patients with and without DM. In addition, incidences of MACEs (4.9% vs 4.8%, p = 1.00) and target lesion revascularization (4.4% vs 4.1%, p = 0.84) were similar. Patients who had insulin-dependent DM manifested higher prevalences of restenosis (25.0% vs 8.5%, p = 0.04) and MACEs (17.2% vs 3.1%, p = 0.01) compared with patients who had non-insulin-dependent DM. In conclusion, in this study of real-world patients who underwent DES implantation, patients who had DM had restenotic rates and clinical outcomes that were similar to those in patients who did not have DM.

Original languageEnglish
Pages (from-to)1389-1392
Number of pages4
JournalAmerican Journal of Cardiology
Volume96
Issue number10
DOIs
Publication statusPublished - 2005 Nov 15

Fingerprint

Drug-Eluting Stents
Diabetes Mellitus
Incidence
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Myocardial Infarction

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Yang, Tae Hyun ; Park, Seong Wook ; Hong, Myeongki ; Park, Duk Woo ; Park, Kyoung Min ; Kim, Young Hak ; Han, Ki Hoon ; Cheol, Whan Lee ; Cheong, Sang Sig ; Kim, Jae Joong ; Park, Seung Jung. / Impact of diabetes mellitus on angiographic and clinical outcomes in the drug-eluting stents era. In: American Journal of Cardiology. 2005 ; Vol. 96, No. 10. pp. 1389-1392.
@article{9773850ad865434c8c771cdacb3505bf,
title = "Impact of diabetes mellitus on angiographic and clinical outcomes in the drug-eluting stents era",
abstract = "The effect of diabetes mellitus (DM) on angiographic restenosis and clinical outcomes after implantation of drug-eluting stents (DESs) has not been investigated in real-world practice. This study consisted of 226 patients who had DM and 560 patients who did not who underwent DES implantation between February 2003 and December 2003. We retrospectively compared the incidence of 6-month angiographic restenosis and 9-month major adverse cardiac events (MACEs), defined as cardiac death, myocardial infarction, and target lesion revascularization, between patients with and without DM. The 6-month angiographic restenotic rate (10.1{\%} vs 8.2{\%}, p = 0.41) and late loss (0.41 ± 0.63 vs 0.36 ± 0.65, p = 0.31) were similar between patients with and without DM. In addition, incidences of MACEs (4.9{\%} vs 4.8{\%}, p = 1.00) and target lesion revascularization (4.4{\%} vs 4.1{\%}, p = 0.84) were similar. Patients who had insulin-dependent DM manifested higher prevalences of restenosis (25.0{\%} vs 8.5{\%}, p = 0.04) and MACEs (17.2{\%} vs 3.1{\%}, p = 0.01) compared with patients who had non-insulin-dependent DM. In conclusion, in this study of real-world patients who underwent DES implantation, patients who had DM had restenotic rates and clinical outcomes that were similar to those in patients who did not have DM.",
author = "Yang, {Tae Hyun} and Park, {Seong Wook} and Myeongki Hong and Park, {Duk Woo} and Park, {Kyoung Min} and Kim, {Young Hak} and Han, {Ki Hoon} and Cheol, {Whan Lee} and Cheong, {Sang Sig} and Kim, {Jae Joong} and Park, {Seung Jung}",
year = "2005",
month = "11",
day = "15",
doi = "10.1016/j.amjcard.2005.07.043",
language = "English",
volume = "96",
pages = "1389--1392",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "10",

}

Yang, TH, Park, SW, Hong, M, Park, DW, Park, KM, Kim, YH, Han, KH, Cheol, WL, Cheong, SS, Kim, JJ & Park, SJ 2005, 'Impact of diabetes mellitus on angiographic and clinical outcomes in the drug-eluting stents era', American Journal of Cardiology, vol. 96, no. 10, pp. 1389-1392. https://doi.org/10.1016/j.amjcard.2005.07.043

Impact of diabetes mellitus on angiographic and clinical outcomes in the drug-eluting stents era. / Yang, Tae Hyun; Park, Seong Wook; Hong, Myeongki; Park, Duk Woo; Park, Kyoung Min; Kim, Young Hak; Han, Ki Hoon; Cheol, Whan Lee; Cheong, Sang Sig; Kim, Jae Joong; Park, Seung Jung.

In: American Journal of Cardiology, Vol. 96, No. 10, 15.11.2005, p. 1389-1392.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Impact of diabetes mellitus on angiographic and clinical outcomes in the drug-eluting stents era

AU - Yang, Tae Hyun

AU - Park, Seong Wook

AU - Hong, Myeongki

AU - Park, Duk Woo

AU - Park, Kyoung Min

AU - Kim, Young Hak

AU - Han, Ki Hoon

AU - Cheol, Whan Lee

AU - Cheong, Sang Sig

AU - Kim, Jae Joong

AU - Park, Seung Jung

PY - 2005/11/15

Y1 - 2005/11/15

N2 - The effect of diabetes mellitus (DM) on angiographic restenosis and clinical outcomes after implantation of drug-eluting stents (DESs) has not been investigated in real-world practice. This study consisted of 226 patients who had DM and 560 patients who did not who underwent DES implantation between February 2003 and December 2003. We retrospectively compared the incidence of 6-month angiographic restenosis and 9-month major adverse cardiac events (MACEs), defined as cardiac death, myocardial infarction, and target lesion revascularization, between patients with and without DM. The 6-month angiographic restenotic rate (10.1% vs 8.2%, p = 0.41) and late loss (0.41 ± 0.63 vs 0.36 ± 0.65, p = 0.31) were similar between patients with and without DM. In addition, incidences of MACEs (4.9% vs 4.8%, p = 1.00) and target lesion revascularization (4.4% vs 4.1%, p = 0.84) were similar. Patients who had insulin-dependent DM manifested higher prevalences of restenosis (25.0% vs 8.5%, p = 0.04) and MACEs (17.2% vs 3.1%, p = 0.01) compared with patients who had non-insulin-dependent DM. In conclusion, in this study of real-world patients who underwent DES implantation, patients who had DM had restenotic rates and clinical outcomes that were similar to those in patients who did not have DM.

AB - The effect of diabetes mellitus (DM) on angiographic restenosis and clinical outcomes after implantation of drug-eluting stents (DESs) has not been investigated in real-world practice. This study consisted of 226 patients who had DM and 560 patients who did not who underwent DES implantation between February 2003 and December 2003. We retrospectively compared the incidence of 6-month angiographic restenosis and 9-month major adverse cardiac events (MACEs), defined as cardiac death, myocardial infarction, and target lesion revascularization, between patients with and without DM. The 6-month angiographic restenotic rate (10.1% vs 8.2%, p = 0.41) and late loss (0.41 ± 0.63 vs 0.36 ± 0.65, p = 0.31) were similar between patients with and without DM. In addition, incidences of MACEs (4.9% vs 4.8%, p = 1.00) and target lesion revascularization (4.4% vs 4.1%, p = 0.84) were similar. Patients who had insulin-dependent DM manifested higher prevalences of restenosis (25.0% vs 8.5%, p = 0.04) and MACEs (17.2% vs 3.1%, p = 0.01) compared with patients who had non-insulin-dependent DM. In conclusion, in this study of real-world patients who underwent DES implantation, patients who had DM had restenotic rates and clinical outcomes that were similar to those in patients who did not have DM.

UR - http://www.scopus.com/inward/record.url?scp=27644526904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27644526904&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2005.07.043

DO - 10.1016/j.amjcard.2005.07.043

M3 - Article

VL - 96

SP - 1389

EP - 1392

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 10

ER -